Cargando…
A Cross‐Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disorder caused by mutations in FGF23, GALNT3, KLOTHO, or FGF23 autoantibodies. Prominent features include high blood phosphate and calcific masses, usually adjacent to large joints. Dental defects have been reported,...
Autores principales: | Lee, Alisa E, Chu, Emily Y, Gardner, Pamela J, Duverger, Olivier, Saikali, Amanda, Wang, Sean K, Gafni, Rachel I, Hartley, Iris R, Ten Hagen, Kelly G, Somerman, Martha J, Collins, Michael T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101615/ https://www.ncbi.nlm.nih.gov/pubmed/33977199 http://dx.doi.org/10.1002/jbm4.10470 |
Ejemplares similares
-
Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management
por: Boyce, Alison M., et al.
Publicado: (2020) -
Familial Hyperphosphatemic Tumoral Calcinosis
por: Saifuddin, Mohammad, et al.
Publicado: (2023) -
Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use
por: Puar, Akshan, et al.
Publicado: (2022) -
A novel FGF23 mutation in hyperphosphatemic familial tumoral calcinosis and its deleterious effect on protein O-glycosylation
por: Zuo, Qingyao, et al.
Publicado: (2022) -
Hyperphosphatemic Tumoral Calcinosis after Total Knee Arthroplasty
por: Mochizuki, Takeshi, et al.
Publicado: (2017)